Welcome to the JINARC® (tolvaptan) training website for healthcare professionals (HCPs) in the UK.The Medicines and Healthcare Products Regulatory Agency (MHRA) requires Otsuka UK to ensure healthcare professionals who prescribe Jinarc have access to educational materials that provide important information regarding the appropriate use of the drug. Healthcare professionals can also register their details in the Enrolment form once they have read and understood the educational materials.This will enable Otsuka to send annual reminders to the trainees to update their training on the RMP materials.Therefore, any HCP wishing to prescribe Jinarc can complete the following:
The content of this website is managed by Otsuka Pharmaceuticals (U.K.) Ltd.
This website is funded by Otsuka Pharmaceuticals Europe Ltd.
- Step 1: Training materials
- Step 2: Enrolment form
The content of this website is managed by Otsuka Pharmaceuticals (U.K.) Ltd.
This website is funded by Otsuka Pharmaceuticals Europe Ltd.
Step 1|Training materials
Patient Alert Card
Discover moreIntended to be carried by patients with autosomal dominant polycystic kidney disease who are being treated with Jinarc.
The patient alert card contains important safety information about Jinarc for patients and carers.
It includes information on hepatic toxicity, severe dehydration and advice should such symptoms occur.